Stem Inc SEC Filings

Stem (STEM) filed a Form 144 notice for a proposed sale of 5,416 common shares on the NYSE. The filing lists an aggregate market value of $98,986.07, with 8,390,208 shares outstanding. The approximate sale date is 11/10/2025, and the broker is Fidelity Brokerage Services LLC.

The shares were acquired on 11/07/2025 through restricted stock vesting from the issuer as compensation. The notice includes the standard representation that the seller does not know of any material adverse information that has not been publicly disclosed.

Stem, Inc. (STEM)Total revenue was $38.2 million for Q3, up from $29.3 million a year ago, driven by PowerTrack software $9.4 million, Edge hardware $15.6 million, Managed services $6.6 million, and Battery hardware resale $4.3 million. Gross profit rose to $13.6 million from $6.2 million, while net loss improved to $23.8 million from $148.3 million.

Year-to-date, net income of $153.7 million reflects a gain on extinguishment of debt of $220.0 million from a June exchange of convertible notes into 2030 Senior Secured Notes and 439,919 warrants. The new notes carry 11.0% cash interest (or 12.0% PIK). Cash and equivalents were $43.1 million, and management believes liquidity is sufficient for at least the next 12 months. Remaining performance obligations were $389.4 million, with about 18% expected over the next year. Shares outstanding were 8,390,208 as of October 22, 2025, after a 1-for-20 reverse split in June.

Stem, Inc. (STEM) furnished its Third Quarter 2025 results via an 8‑K. On October 29, 2025, the company announced financial results for the quarter ended September 30, 2025 and made its press release available as Exhibit 99.

The materials, including slides, are posted on the Stem Investor Relations website. Consistent with General Instruction B.2., the information is furnished under Items 2.02 and 7.01 and is not deemed filed under Section 18 of the Exchange Act, nor incorporated by reference into Securities Act filings except as expressly stated.

Stem, Inc. amended its bylaws to lower the quorum required to conduct business at stockholder meetings from a majority of the voting power to one-third of the voting power, effective upon Board approval on October 15, 2025. The company cited difficulty achieving a quorum given its large and dispersed stockholder base. This change is intended to reduce the risk of meeting adjournments and the associated added costs for meeting hosting and proxy solicitation, as well as potential operational disruptions and management distractions. The full text of the amendment is filed as Exhibit 3.1.

Brian Musfeldt, Chief Financial Officer of STEM, Inc. (STEM), amended a Form 4 to report equity awards granted on 07/17/2025. The amendment discloses 2,500 RSUs that vest 100% on 08/07/2027, 6,750 PSUs that vest upon meeting a volume-weighted average price target over any consecutive 60 trading-day period, and 1,250 stock options with an exercise price of $9.27 that expire on 07/17/2035 and vest 100% on 08/07/2027. The amended filing corrects omissions and an earlier miscount: the original Form 4 omitted the RSUs and options and reported 5,500 PSUs instead of 6,750 PSUs. All reported awards are listed as direct holdings.

STEM, Inc. filing a Form 144 reports a proposed sale of 134 shares of common stock, with an aggregate market value of $2,670.49, to be sold on or about 10/02/2025 on the NYSE. The shares were acquired by the seller on 09/26/2025 through restricted stock vesting and were received as compensation. The filing lists 8,359,047 shares outstanding for the class. The filer reports no sales of the issuer's securities by the seller in the past three months and includes the standard signer representation that they are not aware of undisclosed material adverse information about the issuer.

Stem, Inc. registers for resale up to 439,919 warrants and up to 439,919 common shares issuable upon exercise of those warrants, issued June 30, 2025, as part of exchanges of its 2028 and 2030 convertible notes. Each warrant is exercisable for one share at $30.00 per share and expires at close of business on December 1, 2030. Stem's common stock trades on the NYSE under STEM; the last reported sale price on September 8, 2025 was $13.50. The prospectus warns of potential dilution, limited warrant liquidity, and directs readers to incorporated SEC filings for risks and financial details.

Stem, Inc. files an S-3 shelf registration describing resale of Common Stock and Warrants held by selling securityholders. The document incorporates by reference Stem's 2024 Form 10-K (filed March 5, 2025), Quarterly Reports on Form 10-Q for periods ended March 31, 2025 and June 30, 2025 (filed April 30 and August 8, 2025), and multiple Form 8-Ks.

The company has authorized 250,000,000 shares of Common Stock and 1,000,000 shares of Preferred Stock. As of August 31, 2025 there were 8,387,658 shares of Common Stock outstanding and 439,919 Warrants outstanding. Each Warrant is exercisable for one share at $30.00 per share and expires December 1, 2030. Warrants include anti-dilution adjustments and other customary terms. Deloitte & Touche LLP audited Stem’s consolidated financial statements for years through December 31, 2024.